Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: An overview and the value of Ki-67 immunostaining

Endocrine Pathology

Volumn 19, Issue 4, 2008, Pages 282-288

  Jamali, Mina ^a   Chetty, Runjan ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Ki 67; Neuroendocrine tumors; Pancreas

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER SURVIVAL; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROENDOCRINE TUMOR; OUTCOME ASSESSMENT; PANCREAS TUMOR; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR GROWTH; CARCINOMA; CHEMISTRY; GASTROINTESTINAL TUMOR; PREDICTION AND FORECASTING;

CARCINOMA, NEUROENDOCRINE; CELL PROLIFERATION; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 60749115714     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-008-9044-0     Document Type: Review

References (60)

1. IM Modlin KD Lye M Kidd 2003 A 5-decade analysis of 13,715 carcinoid tumors Cancer 97 934 61
2. MA Maggard JB O'Connell CY Ko 2004 Updated population-based review of carcinoid tumors Ann Surg 240 117 22
3. TJ White JA Edney JS Thompson FW Karrer BJ Moor 1994 Is there a prognostic difference between functional and nonfunctional islet cell tumors? Am J Surg 168 627 30
4. J Rothenstein SP Cleary GR Pond D Dale S Gallinger MJ Moore J Brierley LL Siu 2008 Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital Am J Clin Oncol. 31 64 70
5. RB Kent JA Van Heerden LH Weiland 1981 Nonfunctioning islet cell tumors Ann Surg 193 185 90
6. DB Evans JM Skibber JE Lee KR Cleary JA Ajani RF Gagel RV Selling CJ Fenoglio RC Merrell RC Hickey 1993 Nonfunctioning islet cell carcinoma of the pancreas Surgery 114 1175 81
7. DK Bartsch T Schilling A Ramaswamy B Gerdes I Celik HJ Wagner B Simon M Rothmund 2000 Management of nonfunctioning islet cell carcinomas World J Surg 24 1418 1424
8. CC Solorzano JE Lee PW Pisters JN Vauthey GD Ayers ME Jean RF Gagel JA Ajani RA Wolff DB Evans 2001 Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients Surgery 130 1078 85
9. L Gullo M Migliori M Falconi P Pederzoli R Bettini R Casadei G Delle Fave VD Corleto C Ceccarelli D Santini P Tomassetti 2003 Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study Am J Gastroenterol 98 2435 9
10. Capella C, Heitz PU, Hufler H, Solcia E, Kloppel G. Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 425:547-60, 1995. doi: 10.1007/BF00199342.
11. G Rindi C Capella E Solcia 2000 Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract Q J Nucl Med 44 13 21
12. G Klöppel A Perren PU Heitz 2004 The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification Ann N Y Acad Sci 1014 13 27
13. R Chetty 2008 Requiem for the term 'carcinoid tumor' in the gastrointestinal tract? Can J Gastroenterol 22 357 8
14. A Faggiano G Mansueto P Ferolla F Milone ML del Basso de Caro G Lombardi A Colao G De Rosa 2008 Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors J Endocrinol Invest 31 216 23
15. MR Wick FM Graeme-Cook 2001 Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information Am J Clin Pathol 115 S28 45
16. G Rindi G Klöppel H Ahlman M Caplin A Couvelard WW de Herder B Erikssson A Falchetti M Falconi P Komminoth M Korner JM Lopes AM McNicol O Nilsson A Perren A Scarpa JY Scoazec B Wiedenmann all other Frascati Consensus Conference participants: European Neuroendocrine Tumor Society (ENETS) 2006 TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system Virchows Arch 449 395 401
17. La Rosa S, Klersy C, Uccella S, Dainese L, Albarello L, Sonzogni A, Doglioni C, Capella C, Solcia E. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol. 2008 Aug 18.
18. Solcia E, Sessa F, Rindi G, Bonato M, Capella C. Pancreatic endocrine tumors: general concepts; nonfunctioning tumors and tumors with uncommon function. In: Dayal Y, ed. Endocrine pathology of the gut and pancreas. Boca Raton, Fla: CRC, pp. 105-31, 1991.
19. C Donow H Baisch PU Heitz G Kloppel 1991 Nuclear DNA content in 27 pancreatic endocrine tumors: correlation with malignancy, survival and expression of glycoprotein hormone alpha chain Virchows Arch 419 463 8
20. BD Kenny JM Sloan PW Hamilton PCH Watt CF Johnston KD Buchanan 1989 The role of morphometry in predicting prognosis in pancreatic islet cell tumors Cancer 64 460 465
21. H Hoffler C Ruhri B Ptitz G Wirnsberger H Hauser 1988 Oncogene expression in endocrine pancreatic tumors Virchows Arch 55 355 61
22. S La Rosa F Sessa F Bosi A Fabbri C Capella 1995 Prognostic factors in nonfunctioning pancreatic endocrine tumors Lab Invest 72 54A
23. G Pelosi G Zamboni C Doglioni S Rodella E Bresaola C Iacono G Serio A Iannucci A Scarpa 1992 Immunodetection of proliferating cell nuclear antigen assesses the growth fraction and predicts malignancy in endocrine tumors of the pancreas Am J Surg Pathol 16 1215 25
24. T Scholzen J Gerdes 2000 Ki-67 protein: from the known and the unknown J Cell Physiol 182 311 22
25. E Endl J Gerdes 2000 The Ki-67 protein: fascinating forms and an unknown function Exp Cell Res. 257 231 7
26. DC Brown KC Gatter 2002 Ki67 protein: the immaculate deception? Histopathology. 40 2 11
27. S Bruno Z Darzynkiewicz 1992 Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells Cell Prolif 25 31 40
28. JM Bridger IR Kill P Lichter 1998 Association of pKi-67 with satellite DNA of the human genome in early G1 cells Chromosome Res 6 13 24
29. N Braun T Papadopoulos HK Muller-Hermelink 1988 Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cells Virchows Arch 56 25 33
30. J Gerdes H Lemke H Baisch H-H Wacker U Schwab H Stein 1984 Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 133 1710 5
31. M Starborg K Gell E Brundell C Höög 1996 The murine Ki-67 cell proliferation antigen accumulates in the nucleolar and heterochromatic regions of interphase cells and at the periphery of the mitotic chromosomes in a process essential for cell cycle progression J Cell Sci 109 143 53
32. Y Wu H Luo N Kanaan J Wu 2000 The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67 J. Cell Biochem 76 596 604
33. MR Alison 1995 Assessing cellular proliferation: what's worth measuring? Hum Exp Toxicol 14 935 44
34. HJ Heidebrecht F Buck K Haas HH Wacker R Parwaresch 1996 Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the "Ki-67" proteins Cell Prolif 29 413 25
35. G Cattoretti MH Becker G Key M Duchrow C Schluter J Galle J Gerdes 1992 Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections J Pathol 168 357 63
36. DS Rose PH Maddox DC Brown 1994 Which proliferation markers for routine immunohistology? A comparison of five antibodies J Clin Pathol 47 1010 14
37. N Sawhney PA Hall 1992 Ki67-structure, function, and new antibodies J Pathol 168 161 2
38. R Schwarting 1993 Little missed markers and Ki-67 Lab Invest 68 597 9
39. RV Lloyd 1998 Utility of Ki-67 as a prognostic marker in pancreatic endocrine neoplasms Am J Clin Pathol 109 245 7
40. T Shimizu S Tanaka K Haruma Y Kitadai M Yoshihara K Sumii G Kajiyama F Shimamoto 2000 Growth characteristics of rectal carcinoid tumors Oncology 59 229 37
41. C Sökmensüer G Gedikoglu B Uzunalimoglu 2001 Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study Hepato-Gastroenterol 48 720 3
42. S Onogawa S Tanaka S Oka M Morihara Y Kitadai M Sumii M Yoshihara F Shimamoto K Haruma K Chayama 2002 Clinical significance of angiogenesis in rectal carcinoid tumors Oncol Rep 9 489 94
43. TN Moyana J Xiang A Senthilselvan A Kulaga 2000 The spectrum of neuroendocrine differentiation among gastrointestinal carcinoids. Importance of histologic grading, MIB-1, p53, and bcl-2 immunoreactivity Arch Pathol Lab Med 124 570 6
44. CC Li B Xu M Hirokawa Z Qian K Yoshimoto H Horiguchi T Tashiro T Sano 2002 Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract Virchows Arch 440 145 54
45. G Rigaud E Missiaglia PS Moore G Zamboni M Falconi G Talamini A Pesci A Baron D Lissandrini G Rindi P Grigolato P Pederzoli A Scarpa 2001 High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications Cancer Res 61 285 92
46. A Goto T Niki Y Terado J Fukushima M Fukayama 2004 Prevalence of CD99 protein expression in pancreatic endocrine tumors (PETs) Histopathology 45 384 92
47. N Ohike T Morohoshi 2005 Pathological assessment of pancreatic endocrine tumors for metastatic potential and clinical prognosis Endocr Pathol 16 33 40
48. R Bettini L Boninsegna W Mantovani P Capelli C Bassi P Pederzoli GF Delle Fave F Panzuto A Scarpa M Falconi 2008 Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumors Ann Oncol 19 903 8
49. A von Herbay B Sieg G Schürmann WJ Hofmann M Betzler HF Otto 1991 Proliferative activity of neuroendocrine tumors of the gastroenteropancreatic endocrine system: DNA flow cytometric and immunohistological investigations Gut 32 949 53
50. D Furlan R Cerutti S Uccella S La Rosa E Rigoli A Genasetti C Capella 2004 Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract Clin Cancer Res 10 947 57
51. M Kawahara M Kammori H Kanauchi C Noguchi S Kuramoto M Kaminishi H Endo K Takubo 2002 Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumors Eur J Surg Oncol 28 140 6
52. EM Duerr Y Mizukami A Ng RJ Xavier H Kikuchi V Deshpande AL Warshaw J Glickman MH Kulke DC Chung 2008 Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis Endocr Relat Cancer 15 243 56
53. K Hotta T Shimoda Y Nakanishi D Saito 2006 Usefulness of Ki-67 for predicting the metastatic potential of rectal carcinoids Pathol Int 56 591 6
54. BA Alexiev CB Drachenberg JC Papadimitriou 2007 Endocrine tumors of the gastrointestinal tract and pancreas: grading, tumor size and proliferation index do not predict malignant behavior Diagn Pathol 8 2 28
55. V Deshpande C Fernandez-del Castillo A Muzikansky A Deshpande L Zukerberg AL Warshaw GY Lauwers 2004 Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors Am J Surg Pathol 28 1145 53
56. A Ali S Serra SL Asa R Chetty 2006 The predictive value of CK19 and CD99 in pancreatic endocrine tumors Am J Surg Pathol 30 1588 94
57. AM Schmitt M Anlauf V Rousson S Schmid A Kofler F Riniker J Bauersfeld A Barghorn NM Probst-Hensch H Moch PU Heitz G Kloeppel P Komminoth A Perren 2007 WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors Am J Surg Pathol 31 1677 82
58. S La Rosa E Rigoli S Uccella R Novario C Capella 2007 Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumors Histopathology 50 597 606
59. F Milanezi EM Pereira FV Ferreira D Leitão FC Schmitt 2001 CD99/MIC-2 surface protein expression in breast carcinomas Histopathology 39 578 83
60. M Ozdemirli JC Fanburg-Smith DP Hartmann N Azumi M Miettinen 2001 Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement Mod Pathol 14 1175 82